Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA
For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping off the chemical tags that keep genes silenced and allowing those genes to switch back on.
Read original article on Medical Xpress - latest medical and health news stories →